Together, our findings reveal that underlying APOE genotype-specific proteomic differences in non-demented controls exists and may explain the early changes to cerebrovessels and the subsequent propensity for developing AD particularly in APOE4 carriers. This evidence concerns the gene APOE and Alzheimer disease.